Literature DB >> 24360786

Neoadjuvant chemotherapy for breast cancer: any progress?

Marco Colleoni1, Aron Goldhirsch2.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24360786     DOI： 10.1016/S1470-2045(13)70584-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  7 in total

1.  Number of negative lymph nodes as a prognostic factor for ypN0-N1 breast cancer patients undergoing neoadjuvant chemotherapy.

Authors:  Fei Xin; Yue Yu; Zheng-Jun Yang; Li-Kun Hou; Jie-Fei Mao; Li Xia; Xin Wang; Xu-Chen Cao
Journal:  Tumour Biol       Date:  2016-01-05

2.  The diagnostic performance of CESM and CE-MRI in evaluating the pathological response to neoadjuvant therapy in breast cancer: a systematic review and meta-analysis.

Authors:  Sudan Tang; Chunhong Xiang; Quan Yang
Journal:  Br J Radiol       Date:  2020-07-02       Impact factor: 3.039

3.  Women with large (≥3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survival.

Authors:  Jennifer Eremin; Ged Cowley; Leslie G Walker; Elisabeth Murray; Monika Stovickova; Oleg Eremin
Journal:  Springerplus       Date:  2015-01-13

4.  Both carboplatin and bevacizumab improve pathological complete remission rate in neoadjuvant treatment of triple negative breast cancer: a meta-analysis.

Authors:  Xiao-song Chen; Ying Yuan; David H Garfield; Jia-yi Wu; Ou Huang; Kun-wei Shen
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

5.  Alterations of biomarker profiles after neoadjuvant chemotherapy in breast cancer: tumor heterogeneity should be taken into consideration.

Authors:  Xingchen Zhou; Junyong Zhang; Haiqin Yun; Ranran Shi; Yan Wang; Wei Wang; Svetlana Bajalica Lagercrantz; Kun Mu
Journal:  Oncotarget       Date:  2015-11-03

6.  Intravoxel incoherent motion (IVIM) histogram biomarkers for prediction of neoadjuvant treatment response in breast cancer patients.

Authors:  Gene Y Cho; Lucas Gennaro; Elizabeth J Sutton; Emily C Zabor; Zhigang Zhang; Dilip Giri; Linda Moy; Daniel K Sodickson; Elizabeth A Morris; Eric E Sigmund; Sunitha B Thakur
Journal:  Eur J Radiol Open       Date:  2017-08-18

Review 7.  Drug Combinations in Breast Cancer Therapy.

Authors:  Funmilola A Fisusi; Emmanuel O Akala
Journal:  Pharm Nanotechnol       Date:  2019
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.